Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence

Abstract

Bacillus Calmette Guerin (BCG) was designed for protecting children against tuberculosis. Also, it can protect against other infectious diseases through the induction of trained immunity. Due to its heterologous protective effects, the BCG vaccine has been proposed as a treatment option for coronavirus disease-2019 (COVID-19). Epidemiological studies have found that countries without BCG vaccination policy have experienced higher mortality rates related to COVID-19 infection than those with BCG vaccination policy. However, there are some confounding factors such as age, population intensity, immigration, the pandemic phase, and data accuracy that may affect these results. Therefore, this hypothesis should be evaluated by clinical trial studies. Large-scale clinical trials are in progress to investigate if the BCG vaccine could be used as a useful tool for protection against COVID-19 infection.

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2

“…Although children with COVID-19 have mild symptoms and low transmissibility, they are the nexus of SARS-CoV-2 transmission between families, schools and societies, with a ‘shadow pandemic’ on the economics and politics in adult society ( Fig. 5 A) [66] , [88] , [89] , [90] , [91] , [92] , [93] , [94] . The ‘shadow pandemic’ has spawned school closures and mandatory home isolation policies around the world.…”

Rhinitis phototherapy prototype with timer based on light energy

“…Phototheraphy has emerged as a treatment option for allergic rhinitis due to its ability to directly apply light to the nasal cavity with minimal side effects [7], [8]. Allergic rhinitis phototherapy devices available on the market have varying wavelengths and no time limit for the cleansing process to be carried out.…”